A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age

NCT01195571 ·Status: COMPLETED ·Phase: PHASE1

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

NCT03382405 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

NCT01986010 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

NCT05105048 ·Status: COMPLETED ·Phase: PHASE1

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

NCT04232280 ·Status: COMPLETED ·Phase: PHASE2

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

NCT04975893 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

NCT05085366 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

NCT00435396 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

NCT01941056 ·Status: COMPLETED ·Phase: PHASE1

A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

NCT01753167 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients

NCT01769170 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003)

NCT03840174 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

NCT05683457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

NCT01376778 ·Status: COMPLETED ·Phase: PHASE3

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

NCT03486834 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002437 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

NCT01877655 ·Status: COMPLETED ·Phase: PHASE3

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

NCT02103426 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

NCT00439803 ·Status: COMPLETED ·Phase: PHASE1

Cytomegalovirus Cell-Mediated Immunity

NCT00815165 ·Status: COMPLETED

Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine

NCT02594566 ·Status: WITHDRAWN ·Phase: PHASE1

Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants

NCT00722839 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection

NCT03369912 ·Status: WITHDRAWN ·Phase: PHASE2

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

NCT00497796 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis

NCT00002134 ·Status: COMPLETED ·Phase: NA